Table 2 Tissue specificity for replicated genes encoding drug targets.
Drug target gene | LDL-C (OR, 95% CI) | HDL-C (OR, 95% CI) | Triglycerides (OR, 95% CI) | Tissue specificity index (tau) | Top tissues (Z-score > 1) |
|---|---|---|---|---|---|
APOA5 | 2.05 (1.4–3.02)* † | 0.72 (0.6–0.87)* † | 1.21 (1.12–1.31)* † | 1.00 | Liver |
SLC12A3 | 1.94 (1.43–2.63)* | 0.89 (0.86–0.93)* † | 0.75 (0.24–2.33) | 0.98 | Kidney |
CEACAM16 | 1.66 (1.31–2.11)* † | 0.46 (0.27–0.79)* | 0.56 (0.25–1.27) | 0.98 | Pancreas, tonsil |
APOC3 | 2.04 (1.72–2.42)* † | 0.67 (0.58–0.78)* | 1.26 (1.12–1.41)* † | 0.95 | Liver |
APOA4 | 1.51 (1.23–1.86)* † | 0.53 (0.38–0.74)* | 1.27 (1.14–1.43)* † | 0.94 | Small intestine, colon, duodenum |
APOB | 1.5 (1.18–1.9)* † | 1.23 (0.72–2.12) | 0.53 (0.29–0.98)* † | 0.94 | Liver, small intestine |
APOA1 | 1.88 (1.49–2.36)* † | 0.84 (0.63–1.11) | 1.25 (1.12–1.4)* † | 0.93 | Liver, small intestine |
NPC1L1 | 2.01 (1.48–2.73)* † | – | 2.56 (0.75–8.68) | 0.92 | Small intestine, colon, duodenum, liver |
GPR61 | 1.97 (1.56–2.5)* † | 3.02 (0.77–11.91) | 5.14 (1.43–18.48)* | 0.91 | Cerebral cortex, adrenal gland, eye, thyroid gland |
PCSK9 | 1.6 (1.45–1.77)* † | – | – | 0.87 | Liver, lung, pancreas |
APOC1 | 1.31 (1.22–1.41)* † | 0.39 (0.25–0.59)* | 0.51 (0.17–1.47) | 0.85 | Liver |
CETP | 1.49 (1.29–1.72)* | 0.91 (0.87–0.95)* † | 1.98 (1.63–2.4)* † | 0.76 | Lymph node, liver, placenta, spleen |
ADAMTS13 | 11.18 (4.37–28.59)* † | – | - | 0.72 | Liver |
CILP2 | 1.19 (1.01–1.39)* | – | 1.18 (1.0–1.39)* † | 0.71 | Testis, gallbladder, ovary, thyroid gland |
LPL | – | 0.63 (0.49–0.82)* † | 1.68 (1.46–1.92)* † | 0.68 | Adipose tissue, breast, heart muscle, seminal vesicle |
APOE | 1.3 (1.2–1.41)* † | 0.39 (0.26–0.59)* | 0.5 (0.17–1.45) | 0.58 | Liver, adrenal gland |
CELSR2 | 1.97 (1.78–2.18)* † | 0.06 (0.04–0.09)* | – | 0.58 | Cerebral cortex, fallopian tube, skin |
ALDH1A2 | – | 0.89 (0.81–0.99)* | 1.28 (1.07–1.54)* † | 0.55 | Endometrium, blood, cervix, uterine, fallopian tube, eye, seminal vesicle, testis |
ANGPTL4 | – | 0.48 (0.28–0.83)* † | 3.38 (1.02–11.22)* † | 0.50 | Liver, adipose tissue, breast, cerebral cortex, pancreas |
PVR | 1.31 (1.12–1.54)* † | 0.32 (0.11–0.91)* | – | 0.45 | Liver, heart muscle |
NDUFA13 | 1.63 (1.13– 2.35)* | – | 1.18 (1.0–1.39)* † | 0.43 | Testis, blood, heart muscle, skeletal muscle |
CARM1 | 2.27 (1.68–3.05)* † | – | – | 0.38 | Skeletal muscle |
VEGFA | - | 0.22 (0.15–0.3)* | 4.16 (2.45–7.08)* † | 0.33 | Thyroid gland, endometrium, heart muscle, liver, skeletal muscle, urinary bladder |
SIK3 | 1.15 (0.57–2.31) | 0.46 (0.29–0.73)* † | 1.08 (0.98–1.18) | 0.27 | Cerebral cortex, ovary, parathyroid gland, testis, thyroid gland |
TMED1 | 2.06 (1.5–2.83)* † | – | – | 0.26 | Blood, heart muscle, liver, placenta, skeletal muscle |
PSMA5 | 2.47 (1.8–3.39)* † | 0.08 (0.02–0.29)* | – | 0.23 | Liver, cerebral cortex, kidney, skeletal muscle, thyroid gland |
SMARCA4 | 2.22 (1.98–2.49)* † | 0.01 (0.0–0.02)* | – | 0.19 | Cerebral cortex, bone marrow, esophagus, skeletal muscle, skin, testis, tonsil |
RPL7A | 2.29 (1.57–3.36)* † | – | – | 0.19 | Salivary gland, endometrium, lymph node, ovary, pancreas |